Corporate Partners

Abbott is a globally diversified healthcare company with a central purpose to help people live their healthiest possible lives. From removing the regular pain of fingersticks as people manage their diabetes to connecting patients to doctors with real-time information monitoring their hearts, from easing chronic pain and movement disorders to testing half the world’s blood donations to ensure a healthy supply, our purpose is to make the world a better place by bringing life-changing health technologies to the people who need them. That’s our commitment to helping you live your best life.

Website:

www.abbott.com/

Terumo Blood cells and technologies is a medical technology company. Their products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Terumo BCT employees around the world believe in the potential of blood and cells to do even more for patients than they do today.

Twitter:

@terumobct

Website:

www.terumobct.com/

LinkedIn:

https://linkedin.com/company/terumo-bct/

At Gilead, our purpose is to create a healthier world for all people. We continue to confront the biggest public health challenges of our day and make the impossible possible by investing in worldclass science, addressing societal barriers to care and building a culture where our employees can make a real impact together.

Virology

HIV: We are leading the charge to end the epidemic for everyone, everywhere, from the first single tablet regimen to treat HIV, to medicines that help prevent it, to our continued search for a cure.

Viral Hepatitis: We have helped cure millions of people with hepatitis C. As we work to eliminate it by 2030, we are also providing options for people with hepatitis B and D.

COVID-19: We delivered the first approved treatment for COVID-19, now available in 170+ countries. Our research and preparation for future public health crises is ongoing.

Oncology

We are on our way to becoming a top 10 oncology company by 2030 and eventually curing certain cancers through cell therapy. Together with Kite, we have built a world-class oncology portfolio with nearly 50 clinical-stage programs across nearly every tumor type.

Inflammation

We are advancing an early pipeline of potentially best-in-class molecules to control chronic inflammatory and fibrotic diseases.

Twitter:

@GileadSciences

Website:

www.gilead.com/

LinkedIn:

https://uk.linkedin.com/company/gilead-sciences

Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. They accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.

Website:

www.grifols.com

LinkedIn:

https://linkedin.com/company/grifols/

Werfen plays a role in making blood transfusions safe for patients around the world. They market a complete line of traditional immunohematology reagents and fully automated instruments as well as data management software.

Twitter:

@WerfenNA

Website:

www.werfen.com/en

LinkedIn:

https://linkedin.com/company/werfen/

QuidelOrtho Corporation unites the power of Quidel Corporation and Ortho Clinical Diagnostics behind a shared mission of developing and manufacturing innovative technologies that raise the performance of diagnostic testing and create better patient outcomes across the entire healthcare continuum.

Website:

www.quidelortho.com/

The single focus of Fresenius Kabi TCT EMEA is to enable our Transfusion Medicine and Cell Therapies (TCT) customers to achieve their mission in the 100+ countries of the region. We are global leaders in apheresis technology for both blood component collection and extracorporeal therapies, bringing new innovations focused on donor and patient comfort.  Our expert team is dedicated to forming deep partnerships with our customers, listening to their needs and responding with innovative thinking, collaboration and a shared commitment to the donors and patients we both serve.

Twitter:

@FreseniusKabi

Website:

www.fresenius-kabi.com/

LinkedIn:

https://linkedin.com/company/fresenius-kabi-tct-emea/

Founded in 1977 in the North area of France, Macopharma is a major player in blood industry. Its development has always been driven by important innovations resulting from significant investments in research and development and collaborations developed with customers and partners.

Macopharma offers a range of blood processing solutions combining expertise on disposables, equipments, softwares and processing guidelines to support healthcare professionals for safer and higher quality blood components for the benefit of donors and patients.

Website:

www.macopharma.com/

BioMérieux has been a global leader in in vitro diagnostics for more than 50 years, They have always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide. Today, in more than 150 countries through 43 subsidiaries and a large network of distributors, bioMérieux provides diagnostic solutions that improve patient health and ensure consumer safety.

Website:

www.biomerieux.com/ 

Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development. 

Website:

cerus.com/ 

Sysmex Corporation is a world leader in clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. Serving customers for more than 50 years, Sysmex focuses on technological leadership in diagnostic science and information tools that make a difference in the health of people worldwide. Its R&D efforts focus on the development of high-value-added testing and diagnostic technologies that are innovative, original and optimize individual health. Sysmex also seeks to leverage its state-of-the-art technologies for cell, gene and protein analysis. 

Website:

www.sysmex.co.jp/en/

DIAGAST’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable.
Over the last 30 years, DIAGAST has developed unparalleled expertise and know-how in the transfusion sector. DIAGAST develops, manufactures and markets reagents (for blood group determination), miniaturized laboratories for manual analysis and automated systems.

Website:

www.diagast.com/en/

LinkedIn:

https://linkedin.com/company/diagast/

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with approximately 7,900 employees worldwide. Bio-Rad had revenues of $2.9 billion in 2021.

Twitter:

@BioRadDiag

Website:

www.bio-rad.com

LinkedIn:

https://linkedin.com/company/bio-rad

Snibe has been focused on the IVD field for 29 years and is also the first Chinese manufacturer of chemiluminescence immunoassays to get FDA clearance. At present, Snibe has 3 main product lines of chemiluminescence immunoassay, clinical chemistry and molecular diagnosis. Now Snibe's products have covered more than 152 countries globally with installations of over 30000 units. Furthermore, Snibe offers one of the broadest chemiluminescence immunoassay test menus, with 211 parameters including tests for thyroid function, fertility, infectious diseases, tumor markers, and others.

Website:

www.snibe.com/zh_en/en_index.aspx

For decades, Tianhe has been committed to blood bags, consistently upholding stringent standards such as ISO 13485:2016, MDD93/42/EEC, and GMP regulations. Currently, our reach extends to over 100 countries, delivering both our renowned brand and customized OEM solutions.
 
Driven by a relentless pursuit of excellence, Tianhe prioritizes maximum customer satisfaction through meticulous process management and continual improvement. Jiaxing Tianhe Pharmaceutical stands as the optimal partner for the manufacturing of blood bag systems.

Website:

www.jxtianhe.com/

LinkedIn:

https://linkedin.com/company/tianhe-pharmaceutical/